Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer

Gastrointestinal Cancer Research

Volumn 3, Issue 4, 2010, Pages 149-152

  Haley, Michael ^a   Konski, Andre ^a   Li, Tianyu ^b   Cheng, Jonathan D ^b   Maurer, Alan ^b   Haluszka, Oleh ^b   Scott, Walter ^c   Meropol, Neal J ^d   Cohen, Steven J ^e   Freedman, Gary ^a  

^a HENRY FORD HOSPITAL   (United States)

^b Department of Radiation Oncology ^*

^c Department of Internal Medicine   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GLUCOSE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RADIATION DOSE; SCORING SYSTEM; TUMOR LOCALIZATION;

EID: 77958088972     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. van Westreenen HL, Westerterp M, Bossuyt PM, et al: Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22:3805-3812, 2004
2. Konski A, Doss M, Milestone B, et al: The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61:1123-1128, 2005
3. Moureau-Zabotto L, Touboul E, Lerouge D, et al: Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63:340-345, 2005
4. Vrieze O, Haustermans K, De Wever W, et al: Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol 73:269-275, 2004
5. Som P, Atkins HL, Bandoypadhyay D, et al: A fluorinated glucose analog, 2-fluoro-2-deoxy-Dglucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670-675, 1980
6. Torizuka T, Zasadny KR, Wahl RL: Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging 2:281-287, 1999
7. Diederichs CG, Staib L, Glatting G, et al: FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 39:1030-1033, 1998
8. Langen KJ, Braun U, Rota Kops E, et al: The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 34:355-359, 1993
9. Lindholm P, Minn H, Leskinen-Kallio S, et al: Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J Nucl Med 34:1-6, 1993
10. Zhuang HM, Cortes-Blanco A, Pourdehnad M, et al: Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun 22:1123-1128, 2001
11. Wahl RL, Henry CA, Ethier SP: Serum glucose: effects on tumor and normal tissue accumu-lation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 183:643-647, 1992
12. Gorenberg M, Hallett WA, O'Doherty MJ: Does diabetes affect [(18)F]FDG standardized uptake values in lung cancer? Eur J Nucl Med Mol Imaging 29:1324-1327, 2002
13. Chang YC, Yen TC, Ng KK, et al: Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer? Eur J Nucl Med Mol Imaging 32:647-652, 2005
14. Bares R, Klever P, Hauptmann S, et al: F-18 fluoro deoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192:79-86, 1994
15. Zimny M, Bares R, Fass J, et al: Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 24:678-682, 1997
16. Snedecor G, Cochran WG: Statistical Methods. 7th ed. Ames, IA: The Iowa State University Press; 1980
17. McCullagh P, Nelder JA: Generalized Linear Models. 2nd ed. London: Chapman & Hall; 1989
18. Song SY, Kim JH, Ryu JS, et al: FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 63:1053-1059, 2005